TrialJAMA ophthalmology2020

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial.

Arshad M Khanani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.